Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Pozen Inc. v. Par Pharmaceutical, Inc.
Case Number:
6:08-cv-00437
Court:
Nature of Suit:
Judge:
Firms
- Alston & Bird
- Brooks Kushman
- Carlson Caspers
- Carroll Maloney
- Dacus Law Firm
- Gibson Dunn
- Lerner David
- Locke Lord
- McKool Smith
- Parker Bunt
- Potter Minton
- Vinson & Elkins
Companies
Sectors & Industries:
-
August 08, 2011
Pozen Wins Injunction On Generic Treximet
A Texas federal judge ruled Friday that Par Pharmaceutical Cos. Inc. and two other drugmakers had infringed Pozen Inc.'s patents covering the migraine treatment Treximet and barred them from selling generic versions of the drug in the U.S. until certain patents expire.
-
April 15, 2011
Judge Blocks Par Pharma's Generic Treximet
A Texas federal judge on Thursday barred Par Pharmaceutical Cos. Inc. from selling a generic version of Pozen Inc. migraine treatment Treximet in the U.S. until a patent infringement battle over the drug is resolved.